West Pharmaceutical Services | WST - Selling And Administration Expenses

Stock Price
243.39
Daily Change
2.27 0.94%
Monthly
0.82%
Yearly
10.10%
Q1 Forecast
233.65

West Pharmaceutical Services reported $106.5M in Selling and Administration Expenses for its fiscal quarter ending in December of 2025.





Selling And Administration Expenses Change Date
Align Technology USD 441.68M 23.88M Dec/2025
Avanos Medical USD 77.6M 5.9M Sep/2025
Baxter International USD 761M 53M Dec/2025
Becton, Dickinson and Co. USD 1.39B 27M Dec/2025
Cerus USD 19.33M 1.55M Dec/2024
Charles River Laboratories USD 196.14M 18.55M Dec/2025
Cooper Companies USD 419.2M 12M Sep/2025
Dentsply International USD 355M 21M Sep/2025
Haemonetics USD 109.15M 7.54M Dec/2025
ICU Medical USD 155.81M 3.04M Dec/2025
Insulet USD 331.4M 16.2M Dec/2025
Integra LifeSciences USD 169.05M 10.84M Sep/2025
IQVIA Holdings USD 468M 46M Dec/2025
J&J USD 6.75B 831M Dec/2025
Medtronic 2.97B 159M Sep/2025
Merit Medical Systems USD 107.38M 5.72M Sep/2025
Neogen USD 107.5M 1.56M Sep/2025
OraSure Technologies USD -0.06 0.05 Sep/2024
Quidel USD 194.4M 7.5M Dec/2025
Repligen USD 73.66M 2.43M Sep/2025
Rockwell Medical USD 4.04M 330K Jun/2024
Solventum Corp USD 744M 28M Sep/2025
STAAR Surgical USD 59.38M 18.08M Sep/2025
Terumo JPY 105.26B 7.38B Dec/2025
Utah Medical Products USD 1.87M 50K Sep/2024
West Pharmaceutical Services USD 106.5M 3.8M Dec/2025